Header Logo

Connection

NICOLA HANANIA to Antimetabolites

Back to Details
This is a "connection" page, showing publications NICOLA HANANIA has written about Antimetabolites.
NICOLA HANANIA
Connection Strength
0.194
Antimetabolites
  1. Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial. Intensive Care Med. 2021 11; 47(11):1258-1270.
    View in: PubMed
    Score: 0.194
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.